Literature DB >> 12040864

Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes.

Bruce W Bode1, William V Tamborlane, Paul C Davidson.   

Abstract

Intensive diabetes management can be achieved in adults, adolescents, and children with use of CSII. Compared with MDI, CSII has better insulin pharmacokinetics, less variability in insulin absorption, and decreased risk of hypoglycemia; it also offers patients greater flexibility in lifestyle. Careful adjustment of basal and bolus doses and close follow-up, including patient education, are vital to the success of CSII.

Entities:  

Mesh:

Year:  2002        PMID: 12040864     DOI: 10.3810/pgm.2002.05.1200

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  14 in total

1.  Insulin pumps.

Authors:  T Torrance; V Franklin; S Greene
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

Review 2.  Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review.

Authors:  David Kerr; Erik Wizemann; Jakob Senstius; Mette Zacho; Francisco Javier Ampudia-Blasco
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

Review 3.  Boluses in Insulin Therapy.

Authors:  Ralph Ziegler; Guido Freckmann; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2016-07-10

4.  Sources of glycemic variability--what type of technology is needed?

Authors:  Jonas Kildegaard; Toke Folke Christensen; Ole Kristian Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

5.  Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.

Authors:  Bartlomiej Matejko; Katarzyna Cyganek; Barbara Katra; Danuta Galicka-Latala; Malgorzata Grzanka; Maciej T Malecki; Tomasz Klupa
Journal:  Rev Diabet Stud       Date:  2011-08-10

6.  Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes.

Authors:  Rinku Mehra; Ramesh Raman; Margaret L Bayless; William I Sivitz
Journal:  J Diabetes       Date:  2009-12       Impact factor: 4.006

7.  Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control.

Authors:  Ana Chico; Diana Tundidor; Lluis Jordana; Ignasi Saigi; Miguel A Maria; Rosa Corcoy; A de Leiva
Journal:  J Diabetes Sci Technol       Date:  2014-02-05

8.  Metabolic control of TYPE 1 Diabetes in children treated with insulin pump therapy.

Authors:  Snijezana Hasanbegović; Edo Hasanbegović
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

9.  Health-related quality of life in 4-to-6-year-old children with type 1 diabetes mellitus estimated by children and their mothers.

Authors:  Irina L Nikitina; Igor A Kelmanson
Journal:  Eur J Pediatr       Date:  2021-08-23       Impact factor: 3.860

10.  New technologies for diabetes: a review of the present and the future.

Authors:  Neesha Ramchandani; Rubina A Heptulla
Journal:  Int J Pediatr Endocrinol       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.